Comparison of Cardiovascular Risk Factors Between Subjects With and Without Diabetes Mellitus: An Analytical Study

Creative Commons License
Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Comparison of Cardiovascular Risk Factors Between Subjects With and Without Diabetes Mellitus: An Analytical Study

Arefeh Mousavi 1
Saeed Asefzadeh 1
Amir Ziaee 1
Neda Esmailzadehha 1
Azam Ghorbani 1 , *

Authors Information

1 Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, IR Iran
Article information
  • Biotechnology and Health Sciences: February 2016, 3 (1); e34330
  • Published Online: February 22, 2016
  • Article Type: Research Article
  • Received: November 3, 2015
  • Revised: December 30, 2015
  • Accepted: January 11, 2016
  • DOI: 10.17795/bhs-34330

To Cite: Mousavi A, Asefzadeh S, Ziaee A, Esmailzadehha N, Ghorbani A. et al. Comparison of Cardiovascular Risk Factors Between Subjects With and Without Diabetes Mellitus: An Analytical Study, Biotech Health Sci. 2016 ;3(1):e34330. doi: 10.17795/bhs-34330.

Copyright: Copyright © 0, Biotechnology and Health Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Zgibor JC, Wilson RR, Orchard TJ. Has control of hypercholesterolemia and hypertension in type 1 diabetes improved over time? Diabetes Care. 2005; 28(3): 521-6[PubMed]
  • 2. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 2001; 156(1): 1-10[PubMed]
  • 3. Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Annals of internal medicine. 2015; 163(6): 437-51
  • 4. Tuomilehto J. Reducing coronary heart disease associated with type 2 diabetes: lifestyle intervention and treatment of dyslipidaemia. Diabetes Res Clin Pract. 2003; 61 Suppl 1-34[PubMed]
  • 5. Fox CS, Sullivan L, D’Agostino RB, Sr., Wilson PW, Framingham Heart S. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004; 27(3): 704-8[PubMed]
  • 6. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28(1): 88-136[DOI][PubMed]
  • 7. Porez G, Prawitt J, Gross B, Staels B. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res. 2012; 53(9): 1723-37[DOI][PubMed]
  • 8. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18): 1343-50[DOI][PubMed]
  • 9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6): 393-403[DOI][PubMed]
  • 10. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004; 43(10): 1731-7[DOI][PubMed]
  • 11. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003; 107(22): 2864-9[DOI][PubMed]
  • 12. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. European heart journal. 2011;
  • 13. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002; 47(6): 408-26[PubMed]
  • 14. Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S. Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. Glob J Health Sci. 2013; 5(1): 155-65[DOI][PubMed]
  • 15. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-97[PubMed]
  • 16. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002; 40(5): 954-60[PubMed]
  • 17. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation. 1990; 81(3): 987-95[PubMed]
  • 18. Esteghamati A, Khalilzadeh O, Rashidi A, Meysamie A, Haghazali M, Asgari F, et al. Association between physical activity and insulin resistance in Iranian adults: National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Preventive medicine. 2009; 49(5): 402-6
  • 19. Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk factors for heart failure: a population-based case-control study. Am J Med. 2009; 122(11): 1023-8[DOI][PubMed]
  • 20. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003; 26(12): 3230-6[PubMed]
  • 21. American Diabetes A. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002; 25(1): 202-12[PubMed]